A PHASE-I CLINICAL-TRIAL OF RECOMBINANT INTERLEUKIN-2 FOLLOWING HIGH-DOSE CHEMO-RADIOTHERAPY FOR HEMATOLOGICAL MALIGNANCY - APPLICABILITY TO THE ELIMINATION OF MINIMAL RESIDUAL DISEASE

被引：100
作者：
GOTTLIEB, DJ
BRENNER, MK
HESLOP, HE
BIANCHI, ACM
BELLOFERNANDEZ, C
MEHTA, AB
NEWLAND, AC
GALAZKA, AR
SCOTT, EM
HOFFBRAND, AV
PRENTICE, HG
机构：
[1] LONDON HOSP,DEPT HAEMATOL,LONDON E1 1BB,ENGLAND
[2] GLAXO INST MOLEC BIOL,GENEVA,SWITZERLAND
来源：
BRITISH JOURNAL OF CANCER | 1989年 / 60卷 / 04期
关键词：
D O I：
10.1038/bjc.1989.324
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：610 / 615
页数：6
相关论文
共 19 条
[1]  
ADLER A, 1988, BLOOD, V71, P709
[2]  
APPELBAUM FR, 1988, BLOOD, V72, P179
[3]   TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA - A PROSPECTIVE CONTROLLED TRIAL OF BONE-MARROW TRANSPLANTATION VERSUS CONSOLIDATION CHEMOTHERAPY [J].
CHAMPLIN, RE ;
HO, WG ;
GALE, RP ;
WINSTON, D ;
SELCH, M ;
MITSUYASU, R ;
LENARSKY, C ;
ELASHOFF, R ;
ZIGHELBOIM, J ;
FEIG, SA .
ANNALS OF INTERNAL MEDICINE, 1985, 102 (03) :285-291
[4]  
DONOHUE JH, 1983, J IMMUNOL, V130, P2203
[5]  
GARSON OM, 1987, IN PRESS CANCER GENE
[6]   THE HEMODYNAMIC-EFFECTS OF TREATMENT WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS [J].
GAYNOR, ER ;
VITEK, L ;
STICKLIN, L ;
CREEKMORE, SP ;
FERRARO, ME ;
THOMAS, JX ;
FISHER, SG ;
FISHER, RI .
ANNALS OF INTERNAL MEDICINE, 1988, 109 (12) :953-958
[7]   AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ACUTE-LEUKEMIA IN REMISSION [J].
GORIN, NC ;
HERVE, P ;
AEGERTER, P ;
GOLDSTONE, A ;
LINCH, D ;
MARANINCHI, D ;
BURNETT, A ;
HELBIG, W ;
MELONI, G ;
VERDONCK, LF ;
DEWITTE, T ;
RIZZOLI, V ;
CARELLA, A ;
PARLIER, Y ;
AUVERT, B ;
GOLDMAN, J .
BRITISH JOURNAL OF HAEMATOLOGY, 1986, 64 (02) :385-395
[8]  
HESLOP HE, 1988, J IMMUNOL, V140, P3461
[9]   INTERLEUKIN-2 ENHANCES CYTOTOXIC CELL-FUNCTION INVITRO AFTER T-CELL DEPLETED MARROW TRANSPLANTATION [J].
LEGER, O ;
DREXLER, HG ;
REITTIE, JE ;
SECKERWALKER, L ;
PRENTICE, HG ;
BRENNER, MK .
BRITISH JOURNAL OF HAEMATOLOGY, 1987, 67 (03) :273-279
[10]   HIGH-DOSE RECOMBINANT INTERLEUKIN-2 IN THE TREATMENT OF PATIENTS WITH DISSEMINATED CANCER - RESPONSES, TREATMENT-RELATED MORBIDITY, AND HISTOLOGIC-FINDINGS [J].
LOTZE, MT ;
CHANG, AE ;
SEIPP, CA ;
SIMPSON, C ;
VETTO, JT ;
ROSENBERG, SA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (22) :3117-3124
12